Efficacy and safety of bilastine in Japanese patients with perennial allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase III study
Background: Bilastine, a novel non-sedating second-generation H1 antihistamine, has been approved in most European countries since 2010. This study aimed to evaluate the superiority of bilastine over placebo in Japanese patients with perennial allergic rhinitis (PAR). Methods: This randomized, doubl...
Main Authors: | Kimihiro Okubo, Minoru Gotoh, Mikiya Asako, Yasuyuki Nomura, Michinori Togawa, Akihiro Saito, Takayuki Honda, Yoshihiro Ohashi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-01-01
|
Series: | Allergology International |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1323893016300855 |
Similar Items
-
Therapeutic effect of bilastine in Japanese cedar pollinosis using an artificial exposure chamber (OHIO Chamber)
by: Kazuhiro Hashiguchi, et al.
Published: (2017-01-01) -
NEW ORIGINAL ANTIHISTAMINE BILASTINE IN THE TREATMENT OF ALLERGIC RHINITIS
by: A. A. Krivopalov, et al.
Published: (2017-11-01) -
Antihistamines for Allergic Rhinitis Treatment from the Viewpoint of Nonsedative Properties
by: Hideyuki Kawauchi, et al.
Published: (2019-01-01) -
Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine
by: Wang XY, et al.
Published: (2016-04-01) -
Second generation antihistamines: assessment of the efficacy of treatment and tolerance of some preparations of this group (preliminary studies)
by: Małgorzata A. Czarny-Działak, et al.
Published: (2016-04-01)